Filing Details

Accession Number:
0001140361-14-042505
Form Type:
4
Zero Holdings:
No
Publication Time:
2014-11-17 17:11:43
Reporting Period:
2014-11-14
Filing Date:
2014-11-17
Accepted Time:
2014-11-17 17:11:43
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1125345 Macrogenics Inc MGNX Pharmaceutical Preparations (2834) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1587382 E Kathryn Stein 9640 Medical Center Drive
Rockville MD 20850
Senior Vp, Prd Dev & Reg Aff No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2014-11-14 23,211 $0.94 66,416 No 4 M Direct
Common Stock Disposition 2014-11-14 23,211 $23.33 43,205 No 4 S Direct
Common Stock Acquisiton 2014-11-17 2,090 $0.94 45,295 No 4 M Direct
Common Stock Disposition 2014-11-17 2,090 $22.95 43,205 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (right to buy) Disposition 2014-11-14 23,211 $0.00 23,211 $0.94
Common Stock Stock Option (right to buy) Disposition 2014-11-17 2,090 $0.00 2,090 $0.94
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
2,090 2007-07-07 2017-01-06 No 4 M Direct
0 2007-07-07 2017-01-06 No 4 M Direct
Footnotes
  1. The sales reported on this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the reporting person on 6/30/2014.
  2. The price reported in Column 4 is a weighted average price.